Menu
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Everywhere
Threads
This forum
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Info Obat dan Regulator Obat Dunia
Prev
1
…
Go to page
Go
80
81
82
83
84
…
Go to page
Go
126
Next
First
Prev
82 of 126
Go to page
Go
Next
Last
Filters
Show only:
Loading…
F
Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Other Quality-Related Considerations Guidance for Industry
FDA
Jun 16, 2022
Replies
0
Views
261
Jun 16, 2022
FDA
F
E
Start of rolling review for adapted Comirnaty COVID-19 vaccine, CHMP, 15/06/2022
EMA
Jun 15, 2022
Replies
0
Views
376
Jun 15, 2022
EMA
E
F
Q9(R1) Quality Risk Management
FDA
Jun 15, 2022
Replies
0
Views
344
Jun 15, 2022
FDA
F
F
Smitha C. Reddy, M.D./ACRC Studies, LLC - 634702 - 05/27/2022
FDA
Jun 15, 2022
Replies
0
Views
261
Jun 15, 2022
FDA
F
F
Equine Podiatry Solutions, LLC - 633259 - 05/16/2022
FDA
Jun 15, 2022
Replies
0
Views
253
Jun 15, 2022
FDA
F
F
Hybrid Pharma, LLC - 629021 - 06/07/2022
FDA
Jun 15, 2022
Replies
0
Views
278
Jun 15, 2022
FDA
F
F
Remarks by Commissioner Califf to the 2022 FDLI Annual Conference - 06/14/2022
FDA
Jun 15, 2022
Replies
0
Views
254
Jun 15, 2022
FDA
F
F
Using Methods from PFDD Guidance 1 and Guidance 2 as Tools for Including Patient Experience Data in Clinical Trials: Who to Ask and How to Ask - 06/30
FDA
Jun 15, 2022
Replies
0
Views
270
Jun 15, 2022
FDA
F
F
Using Methods from PFDD Guidance 1 and Guidance 2 as Tools for Including Patient Experience Data in Clinical Trials: Lessons Learned about Data Collec
FDA
Jun 15, 2022
Replies
0
Views
318
Jun 15, 2022
FDA
F
F
Latin Foods Market Issues Voluntary Nationwide Recall of Artri King Reforzado Con Ortiga Y Omega 3 Due to the Presence of Undeclared Diclofenac and De
FDA
Jun 15, 2022
Replies
0
Views
312
Jun 15, 2022
FDA
F
F
Endocrinologic and Metabolic Drugs Advisory Committee Roster
FDA
Jun 15, 2022
Replies
0
Views
266
Jun 15, 2022
FDA
F
E
Big Data strategy for veterinary medicines in the EU , , 13/06/2022
EMA
Jun 14, 2022
Replies
0
Views
241
Jun 14, 2022
EMA
E
E
EMA publishes annual report 2021, , 10/06/2022
EMA
Jun 12, 2022
Replies
0
Views
251
Jun 12, 2022
EMA
E
E
EMA recommends withdrawal of marketing authorisation for amfepramone medicines, PRAC, 10/06/2022
EMA
Jun 12, 2022
Replies
0
Views
282
Jun 12, 2022
EMA
E
E
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022, PRAC, 10/06/2022
EMA
Jun 12, 2022
Replies
0
Views
304
Jun 12, 2022
EMA
E
F
Green Pharmaceuticals Inc Issues Voluntary Nationwide Recall of SnoreStop NasoSpray Due to Microbial Contamination
FDA
Jun 12, 2022
Replies
0
Views
276
Jun 12, 2022
FDA
F
F
Division of Hematologic Malignancies 1 (DHM1)
FDA
Jun 12, 2022
Replies
0
Views
265
Jun 12, 2022
FDA
F
F
Ummzy LLC Issues Voluntary Nationwide Recall of Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night Due to the Presence of Undeclared Tadalafil Sil
FDA
Jun 12, 2022
Replies
0
Views
233
Jun 12, 2022
FDA
F
F
Products Marketed for Removing Moles and Other Skin Lesions Can Cause Injuries, Scarring
FDA
Jun 10, 2022
Replies
0
Views
317
Jun 10, 2022
FDA
F
F
FAQs: What happens to EUAs when a public health emergency ends?
FDA
Jun 10, 2022
Replies
0
Views
259
Jun 10, 2022
FDA
F
Prev
1
…
Go to page
Go
80
81
82
83
84
…
Go to page
Go
126
Next
First
Prev
82 of 126
Go to page
Go
Next
Last
You must log in or register to post here.
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
Top